Dengue Literature Review

FcγRIIa Receptor

6 min read

FcγRIIa Receptor

Overview

FcγRIIa (Fc gamma receptor IIa; gene FcγRIIA) is a membrane-bound glycoprotein expressed on leukocytes including monocytes, macrophages, neutrophils, and dendritic cells. It binds the Fc region of IgG antibodies, mediating phagocytosis of immune complexes (IC) and modulating antibody-triggered inflammatory responses. A clinically important single nucleotide polymorphism (SNP) at codon 131 produces two alleles — Histidine (H131) and Arginine (R131) — yielding three genotypes: HH, HR, and RR. By SPR measurement, H131 binds IgG1 slightly more efficiently than R131 (KA ~52 vs ~35 ×10⁵ M⁻¹) and IgG3 essentially identically; the principal difference between the alleles is a 4.5-fold higher affinity for IgG2 in H131 compared to R131 (KA 4.5 vs 1.0 ×10⁵ M⁻¹) (see Bruhns2009 - FcγR Specificity and Affinity for IgG Subclasses). Older literature characterised the H131 allele as higher-affinity for IgG2; Bruhns2009 confirms and precisely quantifies this, while clarifying that IgG1 and IgG3 affinities differ only modestly between alleles.

Key Points from Literature

  • The FcγRIIa-HH genotype was significantly associated with persistent clinical symptoms 2 years after dengue infection compared to HR+RR combined (p = 0.027; OR 2.83, 95% CI 1.01–8.11), particularly musculoskeletal pain (p = 0.036) and neurological complaints (p = 0.008) (see Garcia2009 - Long-term Clinical Symptoms Post-Dengue).
  • HH genotype is a risk factor not only for sequelae but for symptomatic infection itself: HH frequency was 51.5% in DHF, 39.4% in DF, and only 9.1% in asymptomatic individuals from the same 2006 Cuban cohort (p = 0.008) (see Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism).
  • HH vs HR+RR: OR for DHF = 10.56 (95% CI 2.33–54.64, p = 0.00018); OR for DF = 4.33 (95% CI 1.08–20.10, p = 0.018) — both compared to asymptomatic group (see Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism).
  • RR genotype is protective against DHF development: OR = 0.09, p = 0.01; RR is also enriched in asymptomatic individuals, suggesting it confers protection against symptomatic disease (see Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism).
  • Proposed protective mechanism for RR: efficient IgG1/IgG3 binding → phagolysosome formation → immune complex elimination and control of viral dissemination.
  • Proposed risk mechanism for HH: inefficient IgG1/IgG3 binding → failed lysosome fusion → proteolytic evasion → viral dissemination via ADE; also leads to IC accumulation, pro-inflammatory cytokine release (TNF-α, IL-1), and autoimmune tissue damage (see Autoimmunity in Dengue).
  • Havana population baseline: 55% RR, 32% HR, 13% HH — markedly higher RR frequency than Asian populations (6–10% RR), potentially explaining geographic differences in DHF burden (see Garcia2010 - Asymptomatic Dengue FcγRIIa Polymorphism).

FcγRIIa Affinity for IgG Subclasses — Quantitative Reference (Bruhns2009)

Bruhns2009 - FcγR Specificity and Affinity for IgG Subclasses provides the authoritative SPR-based affinity measurements for FcγRIIa variants across all four IgG subclasses:

ReceptorIgG1IgG2IgG3IgG4
FcγRIIA-H13152±124.5±1.09.1±1.31.7±0.4
FcγRIIA-R13135±51.0±0.08.9±0.12.1±0.2
FcγRIIB/C1.2±0.10.3±0.01.7±0.22.0±0.4

All values ×10⁵ M⁻¹. Values in bold mark the principal allele-dependent difference.

Key implications:

  • The dominant allelic difference is IgG2-specific: H131 binds IgG2 4.5× more efficiently than R131. For IgG1 and IgG3, the alleles are functionally similar (~1.5× difference for IgG1; equivalent for IgG3).
  • FcγRIIB (inhibitory receptor) is ~43× weaker than FcγRIIA-H131 for IgG1. FcγRIIB cannot independently intercept ICs — it requires co-engagement with activating FcγRs by the same IC to exert inhibitory signalling (ITIM). This means when activating FcγRIIA captures a dengue IC, there is no effective independent inhibitory checkpoint through FcγRIIB.
  • IgG4 is the only subclass where R131 binds slightly better than H131 (2.1 vs 1.7 ×10⁵ M⁻¹) — a reversal of the IgG2 pattern.

Dengue-specific implication: The conventional model held that HH genotype was disadvantaged due to lower IgG1/IgG3 affinity. Bruhns2009 contradicts this: H131 has higher IgG1 affinity. The meaningful difference between HH and RR individuals in dengue is likely IgG2 handling, not IgG1/IgG3 handling. Whether anti-dengue IgG2 titres are clinically significant remains an open question (see Questions Raised in Bruhns2009 - FcγR Specificity and Affinity for IgG Subclasses).

FCGR2A in the broader dengue host genetics landscape

Guzman2016 (Table 2) lists FCGR2A alongside multiple other host genetic loci associated with dengue susceptibility or severity (see Guzman2016 - Dengue Infection). FCGR2A is the most robustly replicated single-gene association in dengue genetics; confirmed associations across Cuban cohort (Garcia2010) and listed alongside:

  • HLA alleles (multiple associations with DF/DHF susceptibility, varying by population)
  • IL-10 promoter variants (higher IL-10 production → greater DHF risk in some studies)
  • TNF polymorphisms (TNF-α production variants)
  • DC-SIGN (DCSIGN1/CD209) variants — affect monocyte/DC DENV entry
  • Vitamin D receptor (VDR) variants — immune regulation

The FCGR2A H131 allele (HH genotype) is listed under susceptibility DF/DHF; the R131 allele (RR genotype) is listed under resistance/better outcome — consistent with the Garcia2010 Cuban data.

Contradictions & Debates

  • Mechanism revision required: The prior standard explanation — HH genotype has lower IgG1/IgG3 affinity → poor IC clearance → IC accumulation → inflammation — is not supported by Bruhns2009 - FcγR Specificity and Affinity for IgG Subclasses. Bruhns shows H131 (HH allele) binds IgG1 slightly more efficiently than R131 (52 vs 35 ×10⁵ M⁻¹). The Overview of this page has been corrected accordingly. What makes HH worse in dengue remains mechanistically unclear. Three live hypotheses: (1) more efficient IgG1 binding in H131 → over-activation of inflammatory signalling via FcγRIIA-ITAM; (2) the key variable is IgG2 (where H131 has 4.5× advantage), not IgG1 — but anti-dengue IgG2 abundance in secondary infection is not well characterised; (3) the FcγRIIB inhibitory deficit (too weak to provide independent negative feedback) affects all individuals equally and is not the mechanism behind HH-specific risk.
  • Garcia2009/2010 proposed mechanism: The Garcia papers propose that HH impairs IC clearance via failed phagolysosome fusion. This mechanism should be understood as a functional cell biology hypothesis that predates and is not consistent with the Bruhns affinity data. The appropriate revision is not yet available in the dengue literature.

Sources

Graph View

Backlinks